These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 1464115)

  • 1. Synthesis and drug-release characteristics of the conjugates of mitomycin C with N-succinyl-chitosan and carboxymethyl-chitin.
    Song Y; Onishi H; Nagai T
    Chem Pharm Bull (Tokyo); 1992 Oct; 40(10):2822-5. PubMed ID: 1464115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic characteristics and antitumor activity of the N-succinyl-chitosan-mitomycin C conjugate and the carboxymethyl-chitin-mitomycin C conjugate.
    Song Y; Onishi H; Nagai T
    Biol Pharm Bull; 1993 Jan; 16(1):48-54. PubMed ID: 8369752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and drug release characteristics of the conjugates of mitomycin C with glycol-chitosan and N-succinyl-chitosan.
    Sato M; Onishi H; Kitano M; Machida Y; Nagai T
    Biol Pharm Bull; 1996 Feb; 19(2):241-5. PubMed ID: 8850315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo drug release and antitumor characteristics of water-soluble conjugates of mitomycin C with glycol-chitosan and N-succinyl-chitosan.
    Sato M; Onishi H; Takahara J; Machida Y; Nagai T
    Biol Pharm Bull; 1996 Sep; 19(9):1170-7. PubMed ID: 8889036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and in vitro properties of N-succinylchitosan- or carboxymethylchitin-mitomycin C conjugate microparticles with specified size.
    Onishi H; Takahashi H; Yoshiyasu M; Machida Y
    Drug Dev Ind Pharm; 2001 Aug; 27(7):659-67. PubMed ID: 11694013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-succinyl-chitosan as a drug carrier: water-insoluble and water-soluble conjugates.
    Kato Y; Onishi H; Machida Y
    Biomaterials; 2004 Feb; 25(5):907-15. PubMed ID: 14609679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological fate of highly-succinylated N-succinyl-chitosan and antitumor characteristics of its water-soluble conjugate with mitomycin C at i.v. and i.p. administration into tumor-bearing mice.
    Kato Y; Onishi H; Machida Y
    Biol Pharm Bull; 2000 Dec; 23(12):1497-503. PubMed ID: 11145185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lactosaminated and intact N-succinyl-chitosans as drug carriers in liver metastasis.
    Kato Y; Onishi H; Machida Y
    Int J Pharm; 2001 Sep; 226(1-2):93-106. PubMed ID: 11532574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of lactosaminated and intact N-succinylchitosan-mitomycin C conjugates against M5076 liver metastatic cancer.
    Kato Y; Onishi H; Machida Y
    J Pharm Pharmacol; 2002 Apr; 54(4):529-37. PubMed ID: 11999131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of chitin and chitosan derivatives in the pharmaceutical field.
    Kato Y; Onishi H; Machida Y
    Curr Pharm Biotechnol; 2003 Oct; 4(5):303-9. PubMed ID: 14529420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Properties of water-insoluble mitomycin C-albumin conjugate as a sustained release drug delivery system in mice inoculated with Sarcoma 180.
    Tanaka T; Kaneo Y; Miyashita M; Shiramoto S
    Biol Pharm Bull; 1995 Dec; 18(12):1724-8. PubMed ID: 8787796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of chitosan and its derivatives to cancer chemotherapy.
    Kato Y; Onishi H; Machida Y
    In Vivo; 2005; 19(1):301-10. PubMed ID: 15796190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biodisposition characteristics of N-succinyl-chitosan and glycol-chitosan in normal and tumor-bearing mice.
    Kamiyama K; Onishi H; Machida Y
    Biol Pharm Bull; 1999 Feb; 22(2):179-86. PubMed ID: 10077438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological characteristics of lactosaminated N-succinyl-chitosan as a liver-specific drug carrier in mice.
    Kato Y; Onishi H; Machida Y
    J Control Release; 2001 Feb; 70(3):295-307. PubMed ID: 11182200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravesical cationic nanoparticles of chitosan and polycaprolactone for the delivery of Mitomycin C to bladder tumors.
    Bilensoy E; Sarisozen C; Esendağli G; Doğan AL; Aktaş Y; Sen M; Mungan NA
    Int J Pharm; 2009 Apr; 371(1-2):170-6. PubMed ID: 19135514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour cell uptake of lactosaminated and intact N-succinyl-chitosans and antitumour effects of conjugates with mitomycin C.
    Kato Y; Onishi H; Machida Y
    Anticancer Res; 2002; 22(5):2771-6. PubMed ID: 12529995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Release characteristics of cisplatin chitosan microspheres and effect of containing chitin.
    Nishioka Y; Kyotani S; Okamura M; Miyazaki M; Okazaki K; Ohnishi S; Yamamoto Y; Ito K
    Chem Pharm Bull (Tokyo); 1990 Oct; 38(10):2871-3. PubMed ID: 2076575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the carboxymethyl chitosan-containing liposomes for their stability and controlled release of dapsone.
    Alamelu S; Rao KP
    J Microencapsul; 1991; 8(4):505-19. PubMed ID: 1798021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and antitumor activities of mitomycin C beta-(1-->6)-branched (1-->3)-beta-D-glucan conjugate.
    Usui S; Murashima K; Sakai M; Kiho T; Ukai S
    Biol Pharm Bull; 1994 Sep; 17(9):1165-70. PubMed ID: 7841935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laser photolysis of carboxymethylated chitin derivatives in aqueous solution. Part 2. Reaction of OH* and SO4*- radicals with carboxymethylated chitin derivatives.
    Zhai M; Kudoh H; Wach RA; Wu G; Lin M; Muroya Y; Katsumura Y; Zhao L; Nagasawa N; Yoshii F
    Biomacromolecules; 2004; 5(2):458-62. PubMed ID: 15003006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.